News

We are pleased to announce that the new Seegene NovaplexTM MPXV/OPXV Assay (RUO) is now available.

BÜHLMANN Laboratories AG announces a worldwide collaboration with Beckman Coulter for the distribution of fCAL^® turbo and fPELA^® turbo assays. This partnership enables seamless integration of fecal inflammation and digestion marker testing into automated laboratory workflows.

Learn about the calprotectin marker and explore different perspectives : the research lab, clinical value and assay end user experience.

BÜHLMANN Laboratories AG (“BÜHLMANN”) announces the closing of the acquisition by funds advised by KLAR Partners Limited (“KLAR Partners” or “KLAR”) today June 5th, 2024. The acquisition enables BÜHLMANN to support its future as a leading independent specialty in-vitro diagnostics company.